Keywords: Stroke, High-Field MRI, Stem Cell Therapy; Diffusion; Exosomes; SPIO
Motivation: Stroke treatments are hindered by inefficient delivery and patient tolerance. This study examines whether intranasal mesenchymal stem cell-derived extracellular vesicles (EV) can overcome limitations and improve outcomes.
Goal(s): The study seeks to evaluate whether intranasal EV delivery improves recovery by investigating recovered sodium homeostasis and diffusional restrictions.
Approach: Using a preclinical ischemic stroke model, EV were administered intranasally. High-resolution MRI, including spin-echo 1H EPI DWI, T2W FSE and 23Na CSI, were acquired over 21 d.
Results: The EV-treated group displayed reduced damage and sodium imbalances, with the longitudinal consistency of ADC reflecting both reduced lesion volume and necrosis indicative of maintained cellular integrity.
Impact: MRI-based evaluation of intranasal EV therapy provides a reliable approach to monitor recovery and sodium dynamics post-stroke, meeting a critical need for non-invasive, effective treatments and their assessment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords